| Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma J Huang, Q Deng, Q Wang, KY Li, JH Dai, N Li, ZD Zhu, B Zhou, XY Liu, ... Nature genetics 44 (10), 1117-1121, 2012 | 442 | 2012 |
| Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas Q Deng, G Han, N Puebla-Osorio, MCJ Ma, P Strati, B Chasen, E Dai, ... Nature medicine 26 (12), 1878-1887, 2020 | 370 | 2020 |
| Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A DL Zheng, L Zhang, N Cheng, X Xu, Q Deng, XM Teng, KS Wang, ... Journal of hepatology 50 (2), 377-387, 2009 | 228 | 2009 |
| Effective detection of variation in single-cell transcriptomes using MATQ-seq K Sheng, W Cao, Y Niu, Q Deng, C Zong Nature methods 14 (3), 267-270, 2017 | 212 | 2017 |
| MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes C Liu, R Liu, D Zhang, Q Deng, B Liu, HP Chao, K Rycaj, Y Takata, K Lin, ... Nature communications 8 (1), 14270, 2017 | 207 | 2017 |
| E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation Q Deng, Q Wang, WY Zong, DL Zheng, YX Wen, KS Wang, XM Teng, ... Cancer research 70 (2), 782-791, 2010 | 114 | 2010 |
| Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Y Chu, E Dai, Y Li, G Han, G Pei, DR Ingram, K Thakkar, JJ Qin, M Dang, ... Nature medicine 29 (6), 1550-1562, 2023 | 63 | 2023 |
| Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma N Jain, K Hartert, S Tadros, W Fiskus, O Havranek, MCJ Ma, A Bouska, ... Science translational medicine 11 (497), eaav5599, 2019 | 54 | 2019 |
| Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma MCJ Ma, S Tadros, A Bouska, T Heavican, H Yang, Q Deng, D Moore, ... Haematologica 107 (3), 690, 2022 | 53 | 2022 |
| SRPK1 contributes to malignancy of hepatocellular carcinoma through a possible mechanism involving PI3K/Akt B Zhou, Y Li, Q Deng, H Wang, Y Wang, B Cai, ZG Han Molecular and cellular biochemistry 379, 191-199, 2013 | 51 | 2013 |
| ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis J Huang, Y Lin, L Li, D Qing, XM Teng, YL Zhang, X Hu, Y Hu, P Yang, ... Molecular Carcinogenesis: Published in cooperation with the University of …, 2009 | 50 | 2009 |
| SAMD9L inactivation promotes cell proliferation via facilitating G1-S transition in hepatitis B virus-associated hepatocellular carcinoma Q Wang, YY Zhai, JH Dai, KY Li, Q Deng, ZG Han International journal of biological sciences 10 (8), 807, 2014 | 48 | 2014 |
| Follicular lymphoma microenvironment characteristics associated with tumor cell mutations and MHC class II expression G Han, Q Deng, ML Marques-Piubelli, E Dai, M Dang, MCJ Ma, X Li, ... Blood cancer discovery 3 (5), 428-443, 2022 | 41 | 2022 |
| RNA interference against cancer/testis genes identifies dual specificity phosphatase 21 as a potential therapeutic target in human hepatocellular carcinoma Q Deng, KY Li, H Chen, JH Dai, YY Zhai, Q Wang, N Li, YP Wang, ZG Han Hepatology 59 (2), 518-530, 2014 | 24 | 2014 |
| BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma W Fiskus, CP Mill, D Perera, C Birdwell, Q Deng, H Yang, BH Lara, N Jain, ... Leukemia 35 (9), 2621-2634, 2021 | 15 | 2021 |
| Discovering multiple transcripts of human hepatocytes using massively parallel signature sequencing (MPSS) J Huang, P Hao, YL Zhang, FX Deng, Q Deng, Y Hong, XW Wang, ... Bmc Genomics 8, 1-12, 2007 | 15 | 2007 |
| Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells P Strati, X Li, Q Deng, ML Marques-Piubelli, J Henderson, G Watson, ... Cell Reports Medicine 4 (8), 2023 | 7 | 2023 |
| A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma P Strati, A Jallouk, Q Deng, X Li, L Feng, R Sun, S Adkins, S Johncy, ... Blood Advances 7 (21), 6785-6789, 2023 | 6 | 2023 |
| Pathognomonic and epistatic genetic alterations in B-cell non-Hodgkin lymphoma MCJ Ma, S Tadros, A Bouska, TB Heavican, H Yang, Q Deng, D Moore, ... BioRxiv, 674259, 2019 | 6 | 2019 |
| A single-cell atlas of CD19 chimeric antigen receptor T cells X Li, J Henderson, MJ Gordon, I Sheikh, LJ Nastoupil, J Westin, C Flowers, ... Cancer cell 41 (11), 1835-1837, 2023 | 4 | 2023 |
Ruifang LiuRoswell Park Cancer InstituteVerified email at roswellpark.org
